GlassScriptPhysician profile
Neil Schiff
NPI 1831133800
$10,368.49
in general payments reported to CMS, 2019-2025
28 companies · $4,389 in 2025
The $4,389 reported for 2025 was more than what 95% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $825 · 2020: $425 · 2021: $756 · 2022: $1,043 · 2023: $1,104 · 2024: $1,827 · 2025: $4,389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,387 · Travel and Lodging: $1,880 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,386.96 |
| Travel and Lodging | $1,879.82 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $3,427.60 | 2020-2025 | |
| Intersect Ent, INC. | $1,617.43 | 2019-2022 | |
| Inspire Medical Systems, INC. | $1,163.90 | 2023-2025 | Inspire |
| Optinose US, INC. | $711.58 | 2019-2025 | |
| Medtronic, INC. | $640.08 | 2021-2025 | Propel, Sinuva |
| Genzyme Corporation | $616.54 | 2019-2025 | |
| Glaxosmithkline, LLC. | $605.72 | 2023-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $342.24 | 2022-2025 | Dupixent |
| Neurent Medical Limited | $237.42 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Acclarent, INC | $219.53 | 2019-2023 | Trudi Nav Cable |
| Smith+Nephew, INC. | $107.04 | 2025 | Lens 4k |
| Integra Lifesciences Corporation | $96.31 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Palette Life Sciences, INC. | $90.74 | 2021 | |
| Kaleo, INC. | $88.90 | 2019-2022 | |
| Genentech USA, INC. | $76.57 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $52.99 | 2023 | |
| Shockwave Medical, INC | $41.04 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $40.20 | 2025 | Neffy |
| Cumberland Pharmaceuticals, INC. | $29.94 | 2023 | Caldolor |
| Stryker Corporation | $25.09 | 2022 | |
| Arbor Pharmaceuticals, INC. | $23.80 | 2019 | |
| Paratek Pharmaceuticals, INC. | $20.58 | 2025 | Xhance |
| Astrazeneca Pharmaceuticals LP | $19.69 | 2025 | Tezspire |
| Teleflex LLC | $19.12 | 2023 | Urolift |
| Phadia US INC. | $15.47 | 2022 | |
| Hikma Pharmaceuticals USA | $13.33 | 2024 | Ryaltris |
| Alk-Abello, INC | $12.98 | 2019 | |
| Pfizer INC. | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neil Schiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.